( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Dr. Subhash Chand*, Dr. Pravesh Agarwal and 3Dr. Ajay Kumar


AIDS is not a single disease but it is the manifestation of a group of diseases, therefore it is appropriately called as syndrome. Due to infection the immune mechanism breaks down making the host vulnerable to overwhelming fatal infections. HIV primarily causes progressive qualitative and quantitative deficiency of a subset of T lymphocytes called CD4 T cells. CD4 T cell count has become the most quoted single index of cell mediated immunity in HIV infected patients. However, providences in resource-constraint settings may not have access to the well established laboratory measurement, or the cost may be prohibitive resulting in the need for an alternative and effective surrogate marker. Hence, total lymphocyte count (TLC) was evaluated as a probable surrogate marker for CD4 T cell count in this study. Aims: To evaluate the correlation of CD4 T cell count with the Total Lymphocyte Count in HIV infected patients and to find out a critical value of TLC which can predict a CD4 T cell count less than 200/cmm, for the initiation of antiretroviral therapy. Materials and Methods: The prospective study was conducted on the 40 HIV positive patients admitted in the Department Medicine over a period of one year at Indira Gandhi Medical College and Hospital (IGMC) Shimla. The Complete Blood count, CD4 T cell count and Total Lymphocyte count were measured. The Sensitivity, specificity and positive predictive value of Total Lymphocyte count computed to find out CD4 T cell count <200/cmm. using spearman, s rank correlation. Results: A positive correlation between Total Lymphocyte count and CD4 T count was observed in our study. The Total Lymphocyte count of 1700/cmm was able to predict CD4 T cell count <200/cmm with highest sensitivity (72%), specificity (100%) and positive predictive value (100%). Conclusions: The Total Lymphocyte count 1700 cells/ cmm was the best predictor of CD4 count <200 cells/ cmm and hence TLC can become a reliable marker for the initiation of Antiretroviral therapy resource limited country.

Keywords: Total lymphocyte count, CD 4 T cell, antiretroviral therapy.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on


    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )